The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

Try the newly designed Company Pages!
Switch now

Valeant Pharmaceuticals Intl.

  • VRX
  • TSX
  • Consumer Products
  • Latest 133.92
  • Currency C$
  • Change 2.44
  • Percent Change 1.856 %
  • Volume 197,263
  • Wed Jul 23, 2014 03:50 PM EDT TSX data delayed 15 minutes.
  • Open 131.25
  • Previous Close 131.48
  • High 134.27
  • Low 130.80
  • Bidx200 133.92
  • Askx100 133.95
  • 52-week High02/27 170.45
  • 52-week Low07/23 92.42
  • Beta 0.956
  • Market Cap 44,665.00M
  • EPS -2.85
  • P/E
  • Forward P/E 11.82
  • PEG 0.67
  • Annual Dividend 0.41
  • Yield

News

Financials & Calendars

Income Statement

  • Sales $6,641,369,000
  • Earnings $-861,213,000
  • Return on Equity n/a

Cash Flow

  • Cash Flow $1,586,595,000
  • Cash $576,300,000
  • Current Ratio 1.54

12 months ended Mar 31, 2014.

Trailing 12 month results shown above.
All data is in U.S. dollars.

Balance Sheet

  • Assets $27,989,000,000
  • Liabilities $22,785,500,000
  • Liabilities-to-Equity Ratio 4.38

Price Ratios

  • Price to Sales 6.75
  • Price to Book 7.73
  • Price to Cash Flow 28.27

Event Calendar

Event Last   Next  
Earnings May 8 $1.72 Jul 31 $1.91
Surprises May 8 1.16% n/a n/a
Dividends n/a n/a n/a n/a
Splits n/a -- n/a n/a

12 months ended Jul 23, 2014.

A look at major corporate events and financial announcements that are coming up.

Company Information

About the Company

VALEANT PHARMACEUTICALS INTERNATIONAL, INC. is a specialty pharmaceutical company engaged in the formulation, clinical testing, registration, manufacture and commercialization of pharmaceutical products. The company is focused on the development and commercialization of medicines that address unmet medical needs in specialty CNS markets.

Related Securities
Symbol Type Latest % Chg

Officers

  • J. Michael Pearson Chairman & C.E.O.
  • Howard B. Schiller E.V.P. & C.F.O.
  • Brian Stolz E.V.P. of Administration & CHC
  • Company Type: PUBLIC
  • Company Status: Active
  • Full-time Employees: 17,200
  • Incorporation: Canada,
    n/a
  • Top 1000 Ranking: Profit: 965
    Revenue: 72
    Assets: 43

Head Office

2150 St. Elzear Blvd. West
Laval, QC
H7L 4A8

Phone: (514)-744-6792
Fax: (514)-7446272

ir@valeant.com
www.valeant.com

Ideas & Discussion

Live Discussion of VRX on StockTwits